Global Bone Grafts and Substitutes Market was valued at US$ 2.9 Bn in 2021 and is expected to reach US$ 6.3 Bn by 2032, finds Future Market Insights (FMI) in a recent market survey. As per the findings of the report spinal fusion segment by the deployment mode will remain pivotal for the market as the bulk of revenue will be generated through this category. It is projected that the spinal fusion segment by the deployment model will account for a CAGR of 6.9% in 2032. The growing number of SCI cases across the world, which is the key factor in the high demand for bone grafts and substitutes in the spinal fusion segment.
Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-15798
The US to Command the Larger Proportion of Bone Grafts and Substitutes Market throughout the Analysis Period
The US commands 37.3% of the market share and is expected to maintain the position intact with an absolute opportunity growth of US$ 1.2 Bn to reach a valuation of US$ 2.4 Bn by 2032. Owing to the rapidly increasing requirement for bone grafts and substitutes in Spinal Cord Injuries (SCIs) cases, its demand in the US is expected to increase. A CDC report has anticipated 67 Mn adults in the country to be arthritis patients by 2030, which will increase the demand for bone grafts since it is an essential requirement for arthritis treatment.
“The application of allograft bone grafts in demineralized bone matrices procedures have significant potential to emerge as a key market driver during the forecast period for the Bone Grafts and Substitutes market.” comments an analyst at Future Market Insights.
Bone Grafts and Substitutes Market: Competition Insights
Currently, Bone Grafts and Substitutes providers are largely aiming at adopting strategies such as mergers, acquisitions, and partnerships. They are working towards finding a balance between expanding their product portfolio and capitalizing on the growing market demand. The key companies operating in the Bone Grafts and Substitutes market include Allosource, DePuySynthes Inc., Baxter, NuVasive Inc., Smith & Nephew, Medtronic, Orthofix Holdings Inc., TBF Tissue Engineering, Stryker Corporation, OrthoFix Medical Inc., MedBone Biomaterials, and SeaSpine.
The key recent developments of Bone Grafts and Substitutes manufacturers are as follows:
- In February 2022, Opus B.A., a highly efficient and synthetic bioactive bone graft solution, was launched by Orthofix Medical Inc. to benefit the process of cervical and lumbar spine fusions.
- In February 2021, Simplify Medical was amassed by NuVasive Inc. to strengthen the company’s cervical portfolio, thus expanding its growth avenues during the forecast period.
- In November 2020, the acquisition of Wright Medical Group N.V. was finalized by Stryker Corporation. The amassing of this medical equipment enterprise specializing in extremities and biologics is anticipated to aid in the enhancement of Stryker Corporation’s bone graft substitute portfolio, in order to expand its position in the market.
- In July 2020, the FDA approved the Altapore Shape bioactive bone graft, by Baxter. The specific attributes of this bone graft among many include enhanced bone growth.
Request for Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-15798
More Insights Available
Future Market Insights, in its new offering, presents an unbiased analysis of the Bone Grafts and Substitutes Market, presenting historical market data (2017-2021) and forecast statistics for the period of 2022-2032.
The study reveals extensive growth in the Bone Grafts and Substitutes Market in terms of Material Type (Allograft and Synthetic), Deployment Mode (Craniomaxillofacial, Dental, Foot & Ankle, Joint Reconstruction, Long Bone, and Spinal Fusion), and across five regions (North America, Latin America, Europe, Asia Pacific and Middle East & Africa).
Key Segments Covered in Market Survey
The Bone Grafts and Substitutes Market is segmented based on material type, deployment mode and region.
By Material Type:
- Allograft
- Demineralized Bone Matrix
- Other Allografts
- Synthetic
- Ceramics
- Composites
- Polymers
- Bone Morphogenic Proteins (BMP)
By Deployment Mode:
- Craniomaxillofacial
- Dental
- Foot & Ankle
- Joint Reconstruction
- Long Bone
- Spinal Fusion
Speak to our Research Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-15798
About Future Market Insights (FMI)
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs